Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernovartis.com
English RSS Feed
Get the latest updates from English RSS Feed directly as they happen.
Follow now 78 followers
Latest posts
Last updated 15 days ago
Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjögren’s disease
15 days ago
Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjögren’s disease arcticnovartis Fri...
Letter to global governments: A call for bold life sciences investment
17 days ago
Letter to global governments: A call for bold life sciences investment angilma1...
Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment
22 days ago
Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth...
Novartis and US government reach agreement on lowering drug prices in the US
about 1 month ago
Novartis and US government reach agreement on lowering drug prices in the...
Novartis ianalumab significantly extends disease control in patients with immune thrombocytopenia with only four once-monthly doses
about 2 months ago
Novartis ianalumab significantly extends disease control in patients with immune thrombocytopenia with...
1 in 4 metastatic breast cancer patients treated with Novartis Kisqali® remain progression-free beyond 4 years
about 2 months ago
1 in 4 metastatic breast cancer patients treated with Novartis Kisqali® remain...
Novartis data underscore pioneering scientific innovation in hematology and oncology at ASH and SABCS
2 months ago
Novartis data underscore pioneering scientific innovation in hematology and oncology at ASH...
Novartis receives FDA approval for Itvisma®, the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)
2 months ago
Novartis receives FDA approval for Itvisma®, the only gene replacement therapy for...
Novartis projects +5-6% cc sales CAGR 2025-2030, with long-term growth backed by 30+ potential high-value pipeline assets
2 months ago
Novartis projects +5-6% cc sales CAGR 2025-2030, with long-term growth backed by...
Novartis announces plans to build flagship manufacturing hub in North Carolina
2 months ago
Novartis announces plans to build flagship manufacturing hub in North Carolina arcticnovartis...
Novartis ianalumab first drug to reduce disease activity and patient burden in Sjögren’s disease Phase III trials
2 months ago
Novartis ianalumab first drug to reduce disease activity and patient burden in...
New Novartis data at ASN Kidney Week and AHA Scientific Sessions demonstrate momentum of broad CRM portfolio and pipeline
2 months ago
New Novartis data at ASN Kidney Week and AHA Scientific Sessions demonstrate...